These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 38336572)
1. The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. Kawada T; Yanagisawa T; Rajwa P; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Pallauf M; König F; Pradere B; Araki M; Nasu Y; Shariat SF Clin Genitourin Cancer; 2024 Apr; 22(2):535-543.e4. PubMed ID: 38336572 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis. Berele BA; Cai Y; Yang G Technol Cancer Res Treat; 2021; 20():15330338211034265. PubMed ID: 34323154 [TBL] [Abstract][Full Text] [Related]
3. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer. Li J; Wang J; Chen R; Bai Y; Lu X Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis. Gao G; Wang Z; Qu X; Zhang Z BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis. Zheng X; Song X; Shao Y; Xu B; Hu W; Zhou Q; Chen L; Zhang D; Wu C; Jiang J Cell Physiol Biochem; 2018; 45(2):720-732. PubMed ID: 29414812 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis. Ibrahim EM; Al-Foheidi ME; Al-Mansour MM; Kazkaz GA Breast Cancer Res Treat; 2014 Dec; 148(3):467-76. PubMed ID: 25361613 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Tumor-infiltrating Lymphocytes on Survival Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Tan HNC; Catedral LIG; San Juan MD J Immunother; 2021 Jan; 44(1):29-40. PubMed ID: 32909965 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A meta-analysis. Ding W; Xu X; Qian Y; Xue W; Wang Y; Du J; Jin L; Tan Y Medicine (Baltimore); 2018 Dec; 97(50):e13301. PubMed ID: 30557978 [TBL] [Abstract][Full Text] [Related]
11. The prognostic values of FOXP3 Sun Y; Wang Y; Lu F; Zhao X; Nie Z; He B Clin Transl Oncol; 2023 Jun; 25(6):1830-1843. PubMed ID: 36692642 [TBL] [Abstract][Full Text] [Related]
12. CD3 high and FoxP3 - tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder. Sun ZJ; Zhao JW; Zhao M; Chen Y; Zhang X; Li HC; Wu GQ; Zhang DH Anticancer Drugs; 2023 Aug; 34(7):844-851. PubMed ID: 36563023 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study. Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration. Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543 [TBL] [Abstract][Full Text] [Related]
15. PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy. Murakami Y; Matsumoto K; Shimizu Y; Ikeda M; Amano N; Shimura S; Ishii D; Sato Y; Iwamura M Urol Oncol; 2021 Mar; 39(3):195.e15-195.e23. PubMed ID: 33071109 [TBL] [Abstract][Full Text] [Related]
16. Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer. Ahn S; Chung YR; Seo AN; Kim M; Woo JW; Park SY PLoS One; 2020; 15(5):e0233037. PubMed ID: 32401825 [TBL] [Abstract][Full Text] [Related]
17. The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. de Ruiter EJ; Ooft ML; Devriese LA; Willems SM Oncoimmunology; 2017; 6(11):e1356148. PubMed ID: 29147608 [No Abstract] [Full Text] [Related]
18. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis. Idos GE; Kwok J; Bonthala N; Kysh L; Gruber SB; Qu C Sci Rep; 2020 Feb; 10(1):3360. PubMed ID: 32099066 [TBL] [Abstract][Full Text] [Related]
19. Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy. Sikic D; Weyerer V; Geppert CI; Bertz S; Lange F; Taubert H; Wach S; Schmitz-Draeger BJ; Wullich B; Hartmann A; Eckstein M Urol Oncol; 2022 Feb; 40(2):63.e19-63.e26. PubMed ID: 34420870 [TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis. Yan Q; Li S; He L; Chen N Front Immunol; 2024; 15():1476365. PubMed ID: 39372398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]